Medican Enterprises
Medican Enterprises, Inc. focuses on sports and entertainment investments, holding stakes in basketball franchises, digital media assets, and sports-related non-fungible tokens (NFTs). The company offers basketball team ownership, sports real estate interests, media content, and digital collectibles. It also manages and develops basketball teams; produces and licenses sports-related media content… Read more
Medican Enterprises (MDCN) - Net Assets
Latest net assets as of September 2022: $28.43 Million USD
Based on the latest financial reports, Medican Enterprises (MDCN) has net assets worth $28.43 Million USD as of September 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($48.24 Million) and total liabilities ($19.82 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $28.43 Million |
| % of Total Assets | 58.92% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 1850.67 |
Medican Enterprises - Net Assets Trend (2000–2022)
This chart illustrates how Medican Enterprises's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Medican Enterprises (2000–2022)
The table below shows the annual net assets of Medican Enterprises from 2000 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $28.43 Million | +57.21% |
| 2021-12-31 | $18.08 Million | +43.47% |
| 2020-12-31 | $12.60 Million | +86.53% |
| 2019-12-31 | $6.76 Million | +181.38% |
| 2014-12-31 | $-8.30 Million | -2696.62% |
| 2013-12-31 | $-296.89K | -188.19% |
| 2012-12-31 | $-103.02K | -22.47% |
| 2011-12-31 | $-84.11K | -10.56% |
| 2010-12-31 | $-76.08K | -12.80% |
| 2009-12-31 | $-67.44K | -11.41% |
| 2008-12-31 | $-60.54K | -32.06% |
| 2007-12-31 | $-45.84K | -4211.39% |
| 2004-12-31 | $1.11K | +100.13% |
| 2003-12-31 | $-876.08K | -226.40% |
| 2002-12-31 | $-268.41K | -0.55% |
| 2001-12-31 | $-266.95K | -38.83% |
| 2000-12-31 | $-192.29K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Medican Enterprises's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 766749300.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $7.46 Million | 26.26% |
| Common Stock | $38.94 Million | 137.00% |
| Total Equity | $28.43 Million | 100.00% |
Medican Enterprises Competitors by Market Cap
The table below lists competitors of Medican Enterprises ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SFLMaven Corp
PINK:SFLM
|
$0.96 |
|
Avix Technologies Inc
PINK:AVIX
|
$0.96 |
|
Artificial Life Inc
PINK:ALIF
|
$0.96 |
|
Tradestar Resources Corporation
PINK:TSRR
|
$0.96 |
|
Snoogoo Corp
PINK:SGOO
|
$0.96 |
|
Canopus BioPharma Incorporated
PINK:CBIA
|
$0.96 |
|
Nexity Financial Corporation
PINK:NXTYQ
|
$0.96 |
|
Greyson International Inc
PINK:GYSN
|
$0.96 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medican Enterprises's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 18,082,496 to 28,426,876, a change of 10,344,380 (57.2%).
- Net income of 6,352,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 16,964,595.
- Other factors increased equity by 20,956,975.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $6.35 Million | +22.35% |
| Other Comprehensive Income | $-16.96 Million | -59.68% |
| Other Changes | $20.96 Million | +73.72% |
| Total Change | $- | 57.21% |
Book Value vs Market Value Analysis
This analysis compares Medican Enterprises's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.14x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2000-12-31 | $0.00 | $0.00 | x |
| 2001-12-31 | $0.00 | $0.00 | x |
| 2002-12-31 | $0.00 | $0.00 | x |
| 2003-12-31 | $0.00 | $0.00 | x |
| 2004-12-31 | $0.00 | $0.00 | x |
| 2005-12-31 | $0.00 | $0.00 | x |
| 2006-12-31 | $0.00 | $0.00 | x |
| 2007-12-31 | $0.00 | $0.00 | x |
| 2008-12-31 | $0.00 | $0.00 | x |
| 2009-12-31 | $0.00 | $0.00 | x |
| 2010-12-31 | $0.00 | $0.00 | x |
| 2011-12-31 | $0.00 | $0.00 | x |
| 2012-12-31 | $0.00 | $0.00 | x |
| 2013-12-31 | $0.00 | $0.00 | x |
| 2014-12-31 | $0.00 | $0.00 | x |
| 2019-12-31 | $0.00 | $0.00 | x |
| 2020-12-31 | $0.00 | $0.00 | x |
| 2021-12-31 | $0.00 | $0.00 | x |
| 2022-12-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Medican Enterprises utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 22.35%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 243.46%
- • Asset Turnover: 0.05x
- • Equity Multiplier: 1.70x
- Recent ROE (22.35%) is below the historical average (1053.92%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 0.00% | -28.04% | 4.69x | 0.00x | $-114.75K |
| 2001 | 0.00% | -17.24% | 5.45x | 0.00x | $-56.73K |
| 2002 | 0.00% | 0.12% | 4.42x | 0.00x | $27.26K |
| 2003 | 0.00% | -125.74% | 5.37x | 0.00x | $-141.39K |
| 2004 | 19969.06% | 0.00% | 0.00x | 16.82x | $222.54K |
| 2005 | 0.00% | 0.00% | 0.00x | 0.00x | $-29.42K |
| 2006 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.69K |
| 2007 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.32K |
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-8.64K |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-160.70 |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.03K |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $376.40 |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-8.60K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-346.31K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-55.69 Million |
| 2019 | 1.75% | 18.98% | 0.02x | 6.10x | $-557.27K |
| 2020 | 30.52% | 348.46% | 0.03x | 3.21x | $2.59 Million |
| 2021 | 0.84% | 3.60% | 0.10x | 2.41x | $-1.66 Million |
| 2022 | 22.35% | 243.46% | 0.05x | 1.70x | $3.51 Million |
Industry Comparison
This section compares Medican Enterprises's net assets metrics with peer companies in the Real Estate Services industry.
Industry Context
- Industry: Real Estate Services
- Average net assets among peers: $860,434,363
- Average return on equity (ROE) among peers: -17.79%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medican Enterprises (MDCN) | $28.43 Million | 0.00% | 0.70x | $0.96 |
| Aroundtown SA (AANNF) | $2.43 Billion | 28.32% | 0.83x | $1.42 Billion |
| AAP Inc (AAPJ) | $-1.00 Million | 0.00% | 0.00x | $1.97 |
| Ambase Corp (ABCP) | $-4.12 Million | 0.00% | 0.00x | $6.43 Million |
| Americann Inc (ACAN) | $1.31 Million | -131.48% | 2.04x | $2.44K |
| Ascendas India Trust (ACNDF) | $1.32 Billion | 9.88% | 1.00x | $831.45 Million |
| Adler Group S.A (ADPPF) | $2.20 Billion | 17.61% | 0.90x | $41.80 Million |
| Agritek Holdings Inc (AGTK) | $487.65K | -21.43% | -0.50x | $5.39K |
| reAlpha Tech Corp. Common Stock (AIRE) | $13.17 Million | -41.42% | 0.60x | $32.30 Million |
| Avalon GloboCare Corp. (ALBT) | $7.31 Million | -47.40% | 0.73x | $2.25 Million |
| Allreal (ALRHF) | $2.64 Billion | 8.00% | 1.23x | $2.39 Billion |